2020 annual financial data
TScan Therapeutics 2020 Net margin
Direct answer
Net margin was -2,408.02%.
Operating income was -26,233,000 USD and net income was -26,127,000 USD.
Operating cash flow was -3,023,000 USD.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,085,000 USD
- Operating income
- -26,233,000 USD
- Net income
- -26,127,000 USD
- Operating cash flow
- -3,023,000 USD